Rein Therapeutics, Inc. (RNTX)
0.791
-0.01
(-1.12%)
USD |
NASDAQ |
Sep 21, 16:00
0.791
0.00 (0.00%)
After-Hours: 20:00
Rein Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.4247 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0005 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0018 |
| September 30, 2022 | 0.003 |
| June 30, 2022 | 0.0035 |
| March 31, 2022 | 0.0036 |
| December 31, 2021 | 0.0037 |
| September 30, 2021 | 0.0038 |
| June 30, 2021 | 0.0039 |
| March 31, 2021 | 0.0098 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0318 |
| September 30, 2020 | 0.4087 |
| June 30, 2020 | 0.3126 |
| March 31, 2020 | 0.5046 |
| December 31, 2019 | 0.3136 |
| September 30, 2019 | 0.225 |
| June 30, 2019 | 0.1744 |
| March 31, 2019 | 0.4138 |
| December 31, 2018 | 0.2726 |
| September 30, 2018 | 0.192 |
| June 30, 2018 | 0.1328 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 65.97M |
| Total Liabilities (Quarterly) | 10.77M |
| Shareholders Equity (Quarterly) | 55.20M |
| Current Ratio | 4.270 |